Skip to content

Sleep Medications Demystified: When They Help and When They Don't

Sleep medicines can help during short, stressful stretches—but they work best as a short-term bridge, not a long-term fix. Here’s when they make sense, when they don’t, and why CBT-I is the first-line treatment for sleep that lasts.

Originally published November 13, 2025

Last reviewed June 1, 2026

Clinical review: Fady Boules, PMHNP-BC

7 min read

If you’re lying awake at night, you’re far from alone—trouble sleeping is common, and a large share of U.S. adults regularly fall short on rest. The good news: you have more options than a prescription bottle. Sleep medicines can help during rough patches, but they work best as a short-term bridge while you build sleep that lasts. Here’s a clear, judgment-free guide to when they help, when they don’t, and what tends to work better over time.

When sleep medicine helps, and why CBT-I is the first-line path to sleep that lasts. Tap the image to read it full size.

When sleep medications can help

  • Short-term, during high-stress periods (grief, an acute crisis) as a bridge while you start Cognitive Behavioral Therapy for Insomnia (CBT-I)—the first-line treatment.1 2

  • For a specific problem like trouble staying asleep: low-dose doxepin may help maintenance insomnia.3

  • When dependence risk is a concern: newer DORAs (dual orexin receptor antagonists) may be an option; trials so far have not shown tolerance or withdrawal, although they are still Schedule IV controlled substances.4

What this means for you: If you need quick relief, a time-limited prescription paired with a clear exit plan and a CBT-I referral is often the safest, most effective path to sleep that lasts.1 2 3

When sleep medications usually aren’t the answer

  • Long-term nightly use, especially in older adults, because of higher risks of falls, confusion, and car crashes with benzodiazepines and the “Z-drugs”.5

  • If you might have untreated obstructive sleep apnea (OSA): sedatives can worsen airway problems. DORAs appear neutral for breathing in OSA, but getting evaluated still matters.6

  • As a substitute for CBT-I: guidelines put CBT-I first for durable improvement.1 7

  • Off-label medicines with weak evidence for chronic insomnia (such as trazodone): AASM suggests not using them.3

How to decide: a 7-step checklist

  1. Track one week with a sleep diary—bedtime, wake time, and night-time awakenings.2

  2. Screen for sleep apnea—loud snoring, witnessed pauses in breathing, morning headaches, daytime sleepiness. Ask about testing if any of these fit.2

  3. Ask about CBT-I—in person, by telehealth, or through the free VA CBT-i Coach app.1 2

  4. If a medication is on the table, set clear goals with your prescriber—for example, reducing the time you spend awake during the night.

  5. Match the medicine to the problem (for example, low-dose doxepin for staying asleep, or a DORA if dependence risk is a concern).3 4

  6. Agree on an exit plan—often a few weeks, set with your prescriber—plus a taper if one is needed. If sleep gets worse when you stop, the rebound insomnia essay explains how to tell rebound from withdrawal or a return of the old insomnia.

  7. Review safety—no alcohol or cannabis with sedatives, don’t drive if you feel groggy, and know the FDA boxed warning for Z-drugs.8 Call 911 for someone who cannot be woken or is breathing slowly; call Poison Help at 1-800-222-1222 for a suspected overdose.

Myths vs Facts

MythFact
“Prescription sleep meds cure insomnia.”They ease symptoms, but lasting recovery usually comes from CBT-I, which is first-line.[1](#ref-1) [2](#ref-2)
“Newer meds can’t have side effects.”Every sleep medicine has risks; DORAs tend to be well-tolerated and trials so far have not shown a withdrawal signal, but they are still Schedule IV controlled substances with their own side effects.[4](#ref-4)
“OTC antihistamines are safe long-term.”AASM suggests not using diphenhydramine for chronic insomnia because the benefit is limited and side effects are common.[3](#ref-3)
“Older adults should try a benzo first.”The Beers Criteria recommend avoiding benzodiazepines and the Z-drugs in adults 65 and older.[5](#ref-5)

Risks, Limitations, and Uncertainties

  • Complex sleep behaviors (such as sleepwalking or sleep-driving) with Z-drugs are rare but serious and carry a boxed warning.8 If you ever sleepwalk, sleep-drive, or do anything you do not remember after a dose, stop that medicine and call your prescriber; the label says not to take it again.

  • Falls, confusion, and car crashes are more likely with benzodiazepines and Z-drugs in older adults.5

  • Long-term data are limited: a 2022 Lancet network meta-analysis found many medicines help in the short term, but their long-term benefit and tolerability are less certain.9

  • Sleep apnea interactions: sedatives may worsen untreated OSA. DORAs looked neutral for breathing in trials, but real-world caution is still wise.6

Alternatives and Adjacent Options

  • CBT-I (first-line): a multi-component therapy with strong evidence.1 7 You can access it in person, by telehealth, or through the free CBT-i Coach app.

  • Exercise: a recent network meta-analysis supports structured physical activity for improving insomnia.10

  • Care coordination: treating pain, anxiety, depression, and substance use that disrupt sleep often improves sleep, too.1 3 Some psychiatric medications affect sleep in their own right, so bring your full medication list to the conversation.

Cost, coverage, and access: Medi-Cal managed-care plans such as IEHP cover behavioral health; ask whether CBT-I is available in network. Brand-name sleep medicines (such as DORAs) may need prior authorization. If cost is a concern, your prescriber or pharmacist can discuss lower-cost generic options.

Frequently Asked Questions

Will I get addicted to sleep medication?

It depends on the medicine. Some older options—benzodiazepines and “Z-drugs”—can lead to tolerance or dependence, while newer DORAs have not shown a withdrawal signal in trials so far, though they are still controlled substances (Schedule IV).4 The safest approach is short-term use with a clear exit plan, alongside CBT-I. Your prescriber can help you weigh the choices for your situation.

How long should I stay on a sleep medicine?

For most people, sleep medicines work best as a short bridge—often a few weeks—while you start CBT-I, the first-line treatment.1 2 Long-term nightly use generally isn’t recommended, especially for older adults.5 Your prescriber can set an exit plan and a gentle taper if you need one; the rebound insomnia essay covers what to expect when you stop.

What is CBT-I, and why is it recommended first?

CBT-I (Cognitive Behavioral Therapy for Insomnia) is a structured, non-medication therapy that retrains the patterns keeping you awake. It has strong evidence for lasting improvement, which is why guidelines put it first.1 7 You can access it in person, by telehealth, or through the free VA CBT-i Coach app.

Are over-the-counter or “natural” sleep aids safer?

“Over-the-counter” and “natural” don’t automatically mean safe. Sleep specialists suggest not relying on diphenhydramine—the active ingredient in many OTC sleep aids—for ongoing insomnia, because the benefit is limited and side effects are common, especially in older adults.3 Melatonin is popular, but the evidence is mixed. It’s worth talking with your clinician before using any of these regularly.

I snore loudly and I’m tired all day—should I just take something to sleep?

Loud snoring and constant daytime sleepiness can be signs of obstructive sleep apnea. Because sedatives can make untreated apnea worse, getting evaluated first is important.6 A screening or sleep study can point you in the right direction—bring it up with your provider before starting a sleep medicine.

Does IEHP or Medi-Cal cover treatment for insomnia?

Medi-Cal managed-care plans such as IEHP cover behavioral health care; ask your plan whether CBT-I is available in network. Some brand-name sleep medicines may need prior authorization, and your care team can help with that paperwork.

Evidence reviewed through September 26, 2026.

References

1. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(2):255-262. doi:10.5664/jcsm.8986.

2. Department of Veterans Affairs and Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea. 2025. Official guideline page. Checked September 26, 2026.

3. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. 2017;13(2):307-349. doi:10.5664/jcsm.6470.

4. Merck Sharp & Dohme LLC. Belsomra (suvorexant) prescribing information, including the Schedule IV controlled-substance designation and the discontinuation studies. DailyMed. DailyMed listing. Checked September 26, 2026.

5. 2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2023;71(7):2052-2081. doi:10.1111/jgs.18372.

6. Yeh WC, Li YS, Chang YP, et al. The efficacy and safety of dual orexin receptor antagonists in obstructive sleep apnea: A systematic review and meta-analysis of randomised controlled trials. Journal of Sleep Research. 2025;34(4):e14399. doi:10.1111/jsr.14399. PMID: 39543812.

7. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine. 2016;165(2):125-133. doi:10.7326/M15-2175.

8. U.S. Food and Drug Administration. Certain prescription insomnia medicines: new boxed warning due to risk of serious injuries caused by sleepwalking, sleep driving and engaging in other activities while not fully awake. Drug Safety Communication, April 30, 2019. FDA safety communication. Checked September 26, 2026.

9. De Crescenzo F, D’Alò GL, Ostinelli EG, et al. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet. 2022;400(10347):170-184. doi:10.1016/S0140-6736(22)00878-9.

10. Bu Z, Liu Z, Shahjalal M, et al. Effects of various exercise interventions in insomnia patients: a systematic review and network meta-analysis. BMJ Evidence-Based Medicine. 2026;31(2):102-113. doi:10.1136/bmjebm-2024-113512.

If you or someone you know is in crisis

  • Call 911 or go to your nearest emergency room for any life-threatening emergency.
  • 988 Suicide & Crisis Lifeline — call or text 988, or chat at 988lifeline.org, available 24/7, free and confidential. En español: marque 988 y oprima 2, o envíe AYUDA al 988. Deaf or hard of hearing: 988 videophone (ASL) or TTY 711 then 988. Veterans: 988 and press 1, or text 838255.
  • Crisis Text Line — text HOME to 741741.
  • The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
  • National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
  • National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
  • Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
  • San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
  • Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
  • California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
  • NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.
Fady Boules, PMHNP-BC

Written and clinically reviewed by Fady Boules, PMHNP-BC

Board-certified psychiatric mental health nurse practitioner. In person in Redlands and by telepsychiatry across California, through Inland Psychiatric Medical Group.

About Fady NPI registry How care works Last reviewed June 1, 2026